2023-05-04 17:23:19 ET
- Definitive Healthcare press release ( NASDAQ: DH ): Q1 GAAP EPS of -$0.11 misses by $0.02 .
- Revenue of $59.2M (+18.2% Y/Y) beats by $1.61M .
-
Based on information as of May 4, 2023, the Company is issuing the following financial guidance.
-
Second Quarter 2023:
- Revenue is expected to be in the range of $60.5 – $61.5 million, a 12% increase year over year.
- Adjusted Operating Income is expected to be in the range of $14.5 – $15.5 million.
- Adjusted EBITDA is expected to be in the range of $16.0 – $17.0 million.
- Adjusted Net Income is expected to be $7.0 – $8.0 million.
- Adjusted Net Income Per Diluted Share is expected to be $0.03– $0.05 per share on approximately 155.2 million weighted-average shares outstanding.
-
Full Year 2023:
- Revenue is expected to be in the range of $249.0 – $255.0 million, up 12% – 15% from prior year.
- Adjusted Operating Income is expected to be in the range of $61.5 – $65.5 million.
- Adjusted EBITDA is expected to be in the range of $67.0 – $71.0 million.
- Adjusted Net Income is expected to be $30.0 – $34.0 million.
- Adjusted Net Income Per Diluted Share is expected to be $0.19 – $0.23 per share on approximately 155.5 million weighted-average shares outstanding.
For further details see:
Definitive Healthcare GAAP EPS of -$0.11 misses by $0.02, revenue of $59.2M beats by $1.61M